Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hyperuricemia in hematological disorders]

J Iwata1

  • 1Division of hematology, Kanto-Rosai Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to Letter, "Autophagy Plays a Crucial Role in Ameloblast Differentiation".

Journal of dental research·2024
Same author

Autophagy Plays a Crucial Role in Ameloblast Differentiation.

Journal of dental research·2023
Same author

FaceBase: A Community-Driven Hub for Data-Intensive Research.

Journal of dental research·2022
Same author

Spatiotemporal MicroRNA-Gene Expression Network Related to Orofacial Clefts.

Journal of dental research·2022
Same author

Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice.

Translational psychiatry·2017
Same author

Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice.

Translational psychiatry·2017

Hyperuricemia, a complication of hematological disorders, can lead to tumor lysis syndrome (TLS) and acute kidney injury. Prevention strategies include hydration, urine alkalization, and allopurinol to inhibit uric acid production.

Area of Science:

  • Hematology
  • Oncology
  • Nephrology

Context:

  • Hyperuricemia frequently accompanies hematological malignancies like leukemias and lymphomas.
  • Tumor lysis syndrome (TLS) is a critical condition characterized by metabolic derangements and potential acute renal failure.
  • TLS arises from rapid cancer cell death following chemotherapy or radiotherapy.

Purpose:

  • To outline the pathophysiology and risk factors associated with tumor lysis syndrome.
  • To detail the recommended management strategies for preventing and controlling TLS.
  • To highlight the significance of hyperuricemia in hematological disorders and its complications.

Summary:

  • Hyperuricemia is a key feature in various hematological disorders and a critical component of TLS.

Related Experiment Videos

  • TLS involves hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia, potentially causing uric acid nephropathy and acute renal failure.
  • Risk factors for TLS include high tumor burden, rapid cell turnover, and kidney involvement by cancer cells.

    • Impact:

    • Effective prevention and management of TLS are crucial for patient outcomes in hematological malignancies.
    • Interventions such as hydration, urine alkalization, and allopurinol are vital for mitigating TLS complications.
    • Understanding TLS pathophysiology aids in early detection and timely therapeutic interventions, reducing morbidity and mortality.